Search Results for "Temab-A"

FDA Fast-Tracks Temab-A for Aggressive Lung Cancer Subtype

The FDA has granted Breakthrough Therapy Designation to Temab-A, a c-Met–directed antibody-drug conjugate, for the treatment of EGFR wild-type nonsquamous non-small cell lung cancer (NSCLC) that has p…